'Anti-tangle’ molecule could aid search for new dementia treatments
Scientists from the Universities of Bath and Bristol have identified a molecule that can prevent tangling of a brain protein that is linked to diseases such as Parkinson’s.
Headlines
Global Industry News
-
Positive, rapid and sustained effects on MDD patients treated with Relmada anti-depressant
from Outsourcing-Pharma.com -
Curavit VCRO chosen to manage study of MedRhythm's neurorehabilitation system for stroke patients
from Outsourcing-Pharma.com -
SMi System's single-molecule imaging technology first to be protected by patent
from Outsourcing-Pharma.com -
Belong.Life launches Tara - an AI SaaS matching cancer patients to clinical trials
from Outsourcing-Pharma.com
Hot Topics
-
Women in Science: ScaleReady’s Jenny Stjernberg and her fervent passion for cell and gene therapies
Emerging Markets -
Polpharma Biologics gets greenlight for first multiple sclerosis biosimilar in Europe
Biosimilars -
Eli Lilly receives UK approval for ulcerative colitis treatment
Pipelines -
China-based biotech receives approval for esophageal cancer treatment
Pipelines -
MC2 Therapeutics bags license rights for hidradenitis suppurativa drug
Emerging Markets -
Genentech and PeptiDream to co-develop radiopharmaceuticals in $1 billion deal
Emerging Markets
